To convert the insights gained from research to practical applications, it is crucial for scientists to study and validate their findings in more than just animals. Biobanks house biological samples like blood and tissues that are donated by patients. Cells that come directly from patients provide the most accurate picture of the disease or condition we are fighting against. Here you will find a list of the biobanks that are making patients’ samples accessible to scientists so that they can develop novel ways of preventing, diagnosing, and treating specific diseases.
BioPortal is a unique research platform at the Jewish General Hospital (JGH)/Lady Davis Institute for Medical Research (LDI) built in partnership with the CERC Chair in Genomic Medicine at McGill University. Its goal is to leverage a bank of biomedical information from thousands of patients to incorporate precision medicine and genomics into clinical decision-making and deliver more effective, precise care to patients. BioPortal currently focuses on improving care for diabetes and will then rapidly expand to other common and rare diseases.
BioPortal is open-access, meaning any group who has REB approval and Data Access Committee endorsement can be given access to the data. Researchers can thus have access to:
For more information about how to access the BioPortal data and/or material, please click here.
You have the power to make a difference! Your gift will support vital research at the Lady Davis Institute for Medical Research (LDI) that will translate into disease prevention, improved diagnoses, earlier detection, new and enhanced therapies, a better quality of life, wellness and hope for all of us.
Faire la différence, vous avez ce don! Votre contribution soutiendra la recherche essentielle menée à l’Institut Lady Davis qui permettra la prévention des maladies, des diagnostics plus précis, des dépistages plus rapides, des traitements innovants et plus performants, une meilleure qualité de vie, le bien-être et l’espoir pour nous tous.
Copyright © 2024 | Lady Davis Institute for Medical Research/Jewish General Hospital
Conception et développement : Yankee Media
